Cargando…
Current and Emerging Pharmacotherapies for the Treatment of Relapsed Small Cell Lung Cancer
Small cell lung cancer (SCLC) is a very aggressive cancer with poor outcome if left untreated, but it is also one of the most chemotherapy responsive cancers. Overall it has a very poor prognosis especially if it is chemotherapy resistant to first line treatment. Second line chemotherapy has not bee...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Libertas Academica
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153118/ https://www.ncbi.nlm.nih.gov/pubmed/21836818 http://dx.doi.org/10.4137/CMO.S5964 |